← Browse by Condition
Medical Condition

locally advanced unresectable gastroesophageal junction gej adenocarcinoma or cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT06902545
Recruiting

A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

Enrollment
377 pts
Location
South Korea
Sponsor
Astellas Pharma Korea, Inc.
View Trial →